CYP11B2-IN-1
CAS No. 1356479-78-1
CYP11B2-IN-1 ( —— )
产品货号. M26133 CAS No. 1356479-78-1
CYP11B2-IN-1 is a CYP11B2 inhibitor with IC50 of 2.3 nM. CYP11B2-IN-1 inhibits CYP11B1 with IC50 of 142 nM.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥1061 | 有现货 |
|
5MG | ¥1596 | 有现货 |
|
10MG | ¥2535 | 有现货 |
|
25MG | ¥4317 | 有现货 |
|
50MG | ¥6221 | 有现货 |
|
100MG | ¥8748 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称CYP11B2-IN-1
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述CYP11B2-IN-1 is a CYP11B2 inhibitor with IC50 of 2.3 nM. CYP11B2-IN-1 inhibits CYP11B1 with IC50 of 142 nM.
-
产品描述CYP11B2-IN-1 is a CYP11B2 inhibitor with IC50 of 2.3 nM. CYP11B2-IN-1 inhibits CYP11B1 with IC50 of 142 nM.(In Vitro):The IC50 of CYP11B2-IN-1 for CYP19 is 1021 nM.(In Vivo):CYP11B2-IN-1 dose-dependently produces aldosterone lowering efficacy without affecting cortisol levels in rhesus pharmacodynamic models. CYP11B2-IN-1 (0.01 and 0.3 mg/kg; i.v.) reduces aldosterone AUC of 62% and 95%, respectively.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number1356479-78-1
-
分子量311.4
-
分子式C18H18FN3O
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCC(C)(O)c1cncc(c1)-c1nc2ccc(F)cc2n1C1CC1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.An Y, Zheng H, Yu Z, Sun Y, Wang Y, Zhao C, Ding W. Functioned hollow glass microsphere as a self-floating adsorbent: Rapid and high-efficient removal of anionic dye. J Hazard Mater. 2020 Jan 5;381:120971. doi: 10.1016/j.jhazmat.2019.120971. Epub 2019 Aug 10. PMID: 31421555.
产品手册
关联产品
-
Negletein
Negletein has anti-inflammatory and immunomodulatory activities via inhibition of TNF-α, iNOS and IL-1β.
-
4-Chlorocinnamic aci...
4-Chlorocinnamic acid is a photosensitive compound. 2-Chlorocinnamic acid and 4-chlorocinnamic acid show potent urease inhibitory activities with the respective IC50 values of 0.66 and 1.10 uM.
-
Bronopol
Bronopol is a Standardized Chemical Allergen. The physiologic effect of bronopol is by means of Increased Histamine Release and Cell-mediated Immunity.